MS
Mahaveer Singh
About Mahaveer Singh
Data last updated:
Mahaveer Singh is a Nominee at Novacrine Therapeutics (Opc) Private Limited (since 2026) and Director at Nimsu Sushma Innovation And Incubation Foundation (since 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee | 27 Aug 2026 | 2026 | Active | ||
| Director | 16 Jun 2025 | 2025 | Active |
Board colleagues of Mahaveer Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shubhangini Rathore | 11915913 | Novacrine Therapeutics (Opc) Private Limited | Director |
| Balvir Singh Tomar | 06957581 | Nimsu Sushma Innovation And Incubation Foundation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahaveer Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahaveer Singh
Mahaveer Singh currently holds 2 directorships: Novacrine Therapeutics (Opc) Private Limited (Nominee, since 27 Aug 2026); Nimsu Sushma Innovation And Incubation Foundation (Director, since 16 Jun 2025).
Mahaveer Singh was first appointed on 16 Jun 2025 as Director at Nimsu Sushma Innovation And Incubation Foundation. The most recent appointment on record is 27 Aug 2026 at Novacrine Therapeutics (Opc) Private Limited.
The current boards of Mahaveer Singh's companies include Shubhangini Rathore (Novacrine Therapeutics (Opc) Private Limited), Balvir Singh Tomar (Nimsu Sushma Innovation And Incubation Foundation).